En la actualidad, las guías basadas en la evidencia constituyen una de las herramientas más útiles para mejorar la salud pública y la práctica clínica. Su finalidad es formular intervenciones con sólidas pruebas de eficacia, evitar riesgos innecesarios, utilizar los recursos de forma eficiente, di...
A potentially severe acute respiratory infection caused by the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2).[1] The clinical presentation is generally that of a respiratory infection
with a symptom severity ranging from a mild common cold-like illness, to a severe viral ...
Betacoronavirus/pathogenicity,
Coronavirus Infections/diagnostic imaging,
Coronavirus Infections/complications,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/diagnostic imaging,
Pneumonia, Viral/drug therapy,
Pneumonia, Viral/complications,
Pandemics/statistics & numerical data,
Symptom Flare Up,
Risk Groups,
China/epidemiology,
Healthcare-Associated Pneumonia/diagnosis,
Health Personnel/organization & administration,
Carrier State/transmission,
Infectious Disease Transmission, Vertical/prevention & control
China has managed to control the coronavirus disease (COVID-19) with confinement measurements and treatment strategies, while other countries are struggling to contain the spread. This study discussesthe guidelines related to COVID-19 in China in order to provide important references for other countries
...
Betacoronavirus/drug effects,
Pneumonia, Viral/epidemiology,
Coronavirus Infections/epidemiology,
China/epidemiology,
Pandemics/prevention & control,
Pandemics/statistics & numerical data,
Epidemiological Monitoring,
Health Information Management/methods,
Interferons/therapeutic use,
Lopinavir/therapeutic use,
Ritonavir/therapeutic use,
Ribavirin/therapeutic use,
Chloroquine/therapeutic use,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy
Bhimraj, Adarsh;
Morgan, Rebecca L;
Shumaker, Amy Hirsch;
Lavergne, Valery;
Baden, Lindsey;
Cheng, Vincent Chi-Chung;
Edwards, Kathryn M;
Gandhi, Rajesh;
Muller, William J;
O’Horo, John C;
Shoham, Shmuel;
Murad, M. Hassan;
Mustafa, Reem A;
Sultan, Shahnaz;
Falck-Ytter, Yngve.
Develop evidence-based rapid guidelines intended to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19....
This document provides rapid advice on the use of medical masks in communities, at home and at healthcare facilities in areas that have reported outbreaks caused by the 2019 novel coronavirus (2019-nCoV). It is intended for public health and infection prevention and control (IPC) professionals, healthcar...
The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic and best use of NHS resources. We have withdrawn our guideline on diagnosing and managing pneumonia in adults until further notice....
The purpose of this guideline is to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection....
The purpose of this guideline is to maximise the safety of patients who need critical care during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources....
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China....
This is the first edition of guidance on infection prevention and control (IPC) strategies for use when infection with a novel coronavirus (2019-nCoV) is suspected. It has been adapted from WHO’s Infection prevention and control during health care for probable or confirmed cases of Middle East respirat...